Company intelligence / Profile preview

Miracle Pharm

Singapore, Singapore

Ownership: Private
Development stage: Other

Overview

Miracle Pharm is a Singapore-based animal health and veterinary medicine company. Established in 2023, it operates as a wholly-owned subsidiary of Wuhan Hvsen Biotechnology, a prominent Chinese veterinary pharmaceutical company. Miracle Pharm serves as an international holding and wholesale trade hub, facilitating the global distribution of veterinary drugs, feed additives, and animal health products. Through its own subsidiary, Viet Thanh Biotechnology, the company is expanding its manufacturing footprint in Vietnam, focusing on biotechnology products and veterinary medicines. This strategic positioning allows Miracle Pharm to drive the international expansion of its parent company's portfolio across Southeast Asia.

Industry: Veterinary

Beyond the preview

Go deeper on Miracle Pharm.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Miracle Pharm.

Explore the full profile